Shiva Texyarn Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 10:19 pm

Competitors of Shiva Texyarn Ltd

All Competitor Stocks of Shiva Texyarn Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:45 am

Below is a detailed analysis of the quarterly data for Shiva Texyarn Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 76.18 Cr.. The value appears to be declining and may need further review. It has decreased from 91.58 Cr. (Mar 2025) to 76.18 Cr., marking a decrease of 15.40 Cr..
• For Expenses, as of Jun 2025, the value is 67.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.61 Cr. (Mar 2025) to 67.17 Cr., marking a decrease of 15.44 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.01 Cr.. The value appears strong and on an upward trend. It has increased from 8.97 Cr. (Mar 2025) to 9.01 Cr., marking an increase of 0.04 Cr..
• For OPM %, as of Jun 2025, the value is 11.83%. The value appears strong and on an upward trend. It has increased from 9.79% (Mar 2025) to 11.83%, marking an increase of 2.04%.
• For Other Income, as of Jun 2025, the value is 0.39 Cr.. The value appears to be declining and may need further review. It has decreased from 1.12 Cr. (Mar 2025) to 0.39 Cr., marking a decrease of 0.73 Cr..
• For Interest, as of Jun 2025, the value is 2.89 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.69 Cr. (Mar 2025) to 2.89 Cr., marking a decrease of 0.80 Cr..
• For Depreciation, as of Jun 2025, the value is 3.63 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.54 Cr. (Mar 2025) to 3.63 Cr., marking an increase of 0.09 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.88 Cr.. The value appears strong and on an upward trend. It has increased from 2.86 Cr. (Mar 2025) to 2.88 Cr., marking an increase of 0.02 Cr..
• For Tax %, as of Jun 2025, the value is 14.93%. The value appears to be increasing, which may not be favorable. It has increased from -115.73% (Mar 2025) to 14.93%, marking an increase of 130.66%.
• For Net Profit, as of Jun 2025, the value is 2.46 Cr.. The value appears to be declining and may need further review. It has decreased from 6.17 Cr. (Mar 2025) to 2.46 Cr., marking a decrease of 3.71 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.90. The value appears to be declining and may need further review. It has decreased from 4.76 (Mar 2025) to 1.90, marking a decrease of 2.86.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:06 pm

Growth

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: November 9, 2025, 2:55 pm

Below is a detailed analysis of the balance sheet data for Shiva Texyarn Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For Reserves, as of Sep 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 7.00 Cr..
• For Borrowings, as of Sep 2025, the value is 104.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 106.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 61.00 Cr.. The value appears to be improving (decreasing). It has decreased from 63.00 Cr. (Mar 2025) to 61.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 308.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 304.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 4.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 166.00 Cr.. The value appears to be declining and may need further review. It has decreased from 168.00 Cr. (Mar 2025) to 166.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Sep 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Sep 2025, the value is 139.00 Cr.. The value appears strong and on an upward trend. It has increased from 133.00 Cr. (Mar 2025) to 139.00 Cr., marking an increase of 6.00 Cr..
• For Total Assets, as of Sep 2025, the value is 308.00 Cr.. The value appears strong and on an upward trend. It has increased from 304.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 4.00 Cr..

Notably, the Reserves (130.00 Cr.) exceed the Borrowings (104.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Shiva Texyarn Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 9.31. This value is within the healthy range. It has increased from -8.31 (Mar 24) to 9.31, marking an increase of 17.62.
• For Diluted EPS (Rs.), as of Mar 25, the value is 9.31. This value is within the healthy range. It has increased from -8.31 (Mar 24) to 9.31, marking an increase of 17.62.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.38. This value is within the healthy range. It has increased from 3.13 (Mar 24) to 20.38, marking an increase of 17.25.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 104.66. It has increased from 95.03 (Mar 24) to 104.66, marking an increase of 9.63.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 104.66. It has increased from 95.03 (Mar 24) to 104.66, marking an increase of 9.63.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 248.95. It has decreased from 258.65 (Mar 24) to 248.95, marking a decrease of 9.70.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 27.73. This value is within the healthy range. It has increased from 9.58 (Mar 24) to 27.73, marking an increase of 18.15.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.66. This value is within the healthy range. It has increased from -1.86 (Mar 24) to 16.66, marking an increase of 18.52.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.51. This value is within the healthy range. It has increased from -10.66 (Mar 24) to 7.51, marking an increase of 18.17.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 9.30. This value is within the healthy range. It has increased from -8.30 (Mar 24) to 9.30, marking an increase of 17.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.30. This value is within the healthy range. It has increased from -8.30 (Mar 24) to 9.30, marking an increase of 17.60.
• For PBDIT Margin (%), as of Mar 25, the value is 11.13. This value is within the healthy range. It has increased from 3.70 (Mar 24) to 11.13, marking an increase of 7.43.
• For PBIT Margin (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 10. It has increased from -0.71 (Mar 24) to 6.69, marking an increase of 7.40.
• For PBT Margin (%), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 10. It has increased from -4.12 (Mar 24) to 3.01, marking an increase of 7.13.
• For Net Profit Margin (%), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 5. It has increased from -3.21 (Mar 24) to 3.73, marking an increase of 6.94.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 8. It has increased from -3.21 (Mar 24) to 3.73, marking an increase of 6.94.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.89. This value is below the healthy minimum of 15. It has increased from -8.74 (Mar 24) to 8.89, marking an increase of 17.63.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.38. This value is within the healthy range. It has increased from -1.29 (Mar 24) to 11.38, marking an increase of 12.67.
• For Return On Assets (%), as of Mar 25, the value is 3.96. This value is below the healthy minimum of 5. It has increased from -3.72 (Mar 24) to 3.96, marking an increase of 7.68.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.24 (Mar 24) to 0.19, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.73. This value is within the healthy range. It has decreased from 0.77 (Mar 24) to 0.73, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has increased from 0.00 (Mar 24) to 1.09, marking an increase of 1.09.
• For Current Ratio (X), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 1.5. It has increased from 0.97 (Mar 24) to 1.07, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. It has decreased from 0.43 (Mar 24) to 0.42, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 4.97, marking an increase of 4.97.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.03. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 3.03, marking an increase of 1.94.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has increased from 0.05 (Mar 24) to 2.02, marking an increase of 1.97.
• For Enterprise Value (Cr.), as of Mar 25, the value is 321.86. It has increased from 277.92 (Mar 24) to 321.86, marking an increase of 43.94.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has increased from 0.82 (Mar 24) to 0.99, marking an increase of 0.17.
• For EV / EBITDA (X), as of Mar 25, the value is 8.95. This value is within the healthy range. It has decreased from 22.38 (Mar 24) to 8.95, marking a decrease of 13.43.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.69, marking an increase of 0.14.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.66, marking an increase of 0.15.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.69, marking an increase of 0.14.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to 0.05, marking an increase of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness